18
Participants
Start Date
April 5, 2017
Primary Completion Date
June 16, 2017
Study Completion Date
June 16, 2017
JNJ-64041575
Two 500-mg tablets administered as a single oral dose under fasted conditions on Day 1 or Day 22.
Probenecid
One 500-mg tablet administered as a single oral dose with a total of 30 doses (2 doses on Day -1/21 starting in the evening followed by 4 doses per day on the rest of the days).
Charité Research Organisation GmbH, Berlin
Lead Sponsor
Janssen-Cilag International NV
INDUSTRY